Description: Breathe easy: improving outcomes in patients with COPD using non-pharmacological therapies. This course offers insight on non-pharmacological therapies based on the GOLD recommendations, as well as, clinical factors to assess a patient’s severity and risk of complications according to the new classification of COPD as defined by the 2017 to the current GOLD recommendations.
Objectives:
- Select four non-pharmacological therapies that improve outcomes in COPD patients
- Identify the minimum number of hours per day that patients with resting hypoxemia need to wear their oxygen to improve their mortality
Target Audience:
This activity is designed for physicians, nurses and other healthcare professionals who provide care or want to provide care to patients with chronic obstructive pulmonary disease.
Accreditation:
UT Health San Antonio School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This enduring material activity created by the WipeDiseases Foundation in chronic obstructive pulmonary disease (COPD), has been reviewed and is acceptable for a maximum of 1.5 hours.
Designation:
UT Health San Antonio School of Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact:
Continuing Medical Education Office
Email: cme@uthscsa.edu
Phone: 1 (866) 601-4448 or (210) 567-4491
Release Date:
AMA PRA Category 1 Credits: January 15, 2019
Termination Date:
AMA PRA Category 1 Credits: January 14, 2022
Financial Support:
The WipeDiseases Foundation’s COPD educational program was supported in part by an unrestricted grant by the American College of Chest Physicians CHEST Foundation, who had no influence regarding any of the content on the site.
Faculty:
- Sandra G. Adams, MD, MS, Chair
- Professor of Medicine
- Pulmonary / Critical Care Division of The University of Texas Health San Antonio (UT Health San Antonio)
- San Antonio, TX
- Catherine “Casey” S. Jones, PhD, RN
- Adjunct Professor
- Texas Woman’s University
- Dallas, TX
Review Committee:
- Brian W. Carlin, MD, FCCP, FAARC, MAACVPR, FAASM
- Sleep Medicine and Lung Health Consultants
- Pittsburgh Critical Care Associates
- Pittsburgh, PA
- Sidney S. Braman, MD Master FCCP
- Professor of Pulmonary, Critical Care and Sleep Medicine Division
- Icahn School of Medicine
- New York, NY
Disclosure of Conflict of Interest Statement:
The following faculty members/activity planners have disclosed to the University of Texas Health Science Center San Antonio, School of Medicine, Office of CME that a relationship does exist with the respective company/organization as it relates to their presentation of material and should be communicated to the participants of this educational activity:
- Sandra G. Adams, MD, MS, FCCP:
- Investigator/Grant/Educational Research: Chest Foundation, National Institute of Health (NIH), Veterans Affairs Cooperative Studies Program, AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc; Daiichi Sankyo; GlaxoSmithKline; Novartis Pharmaceuticals AG; Sunovion
- Brian W. Carlin, MD, FCCP, FAARC, MAACVPR, FAASM:
- Consultant/Advisory Boards: AstraZeneca, GlaxoSmithKline, Monaghan, Philips Respironics, Sunovion
- Speaker’s Bureaus: GlaxoSmithKline, Monaghan, Sunovion
- Fiduciary positions: National Lung Health Education Program (chairperson); National Board for Respiratory Care (board member)
- Sidney S. Braman, MD Master FCCP
- Speaker’s Bureau: Genentech.
- Consultant: Astra Zeneca, Circassia and Sunovion
- Catherine “Casey” S. Jones, PhD, RN
- No potential conflict of interest exists with any respective company/organization
Hardware/Software Requirements:
You will need internet access to view the educational content that is associated with this educational activity. We suggest a Wi-Fi connection of at least 1.5m. You will also need an internet browser capable of playing either flash or html5 video clips.